Neuland Laboratories Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Neuland Laboratories Limited with three other
companies in this sector in India:
Morepen Laboratories Limited
sales of 5.84 billion Indian Rupees [US$91.21 million]
of which 100%
Astrazeneca Pharma India Ltd
(5.40 billion Indian Rupees [US$84.28 million]
of which 96%
was Healthcare), and
Suven Life Sciences Limited
(5.44 billion Indian Rupees [US$84.90 million]
of which 95%
was Intermediaries under Contract Research/M).
Neuland Laboratories Limited reported sales of 5.73 billion Indian Rupees (US$89.46 million)
March of 2017.
increase of 12.3%
versus 2016, when the company's sales were 5.10 billion Indian Rupees.